@dansfera: Cancer cells are learning how to fight back, and the pharmaceutical industry is scrambling to outsmart them. While antibody drug conjugates (ADCs) have been the gold standard for precision cancer treatment, the first generation of these guided missile drugs is becoming crowded and less effective. Now, the real innovation lies in the warhead. With Mirisk pioneering a brand-new, enzyme-blocking payload and Novartis securing the latest technology, the race to develop the next breakthrough in oncology has officially entered a new era. #CancerResearch #Biotech #Novartis #ADCs #ScienceNews

dansfera

Open In TikTok:

Region: US

Wednesday 12 August 2026 06:45:22 GMT